| Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward. | |
| | |
MedLine Citation:
|
PMID: 15078373 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Children who undergo a prolonged stay within the intensive care unit require adequate sedation and analgesia. During the recovery phase there will need to be a period of sedation withdrawal to prevent occurrence of an abstinence syndrome. We present a strategy developed within our hospital for managing this process which uses the resource of the Pain Service, along with guidelines to help prevent the development of withdrawal, and a plan for managing any signs of abstinence which occur. |
| | |
Authors:
|
M Cunliffe; L McArthur; F Dooley |
Related Documents
:
|
10272503 - Training of health workers for developing countries. 16700163 - European practice in haemodialysis: results of the epd. 23196533 - Management of intracranial hemorrhage during anticoagulant therapy with warfarin or nov... |
Publication Detail:
|
Type: Case Reports; Journal Article; Review |
Journal Detail:
|
Title: Paediatric anaesthesia Volume: 14 ISSN: 1155-5645 ISO Abbreviation: Paediatr Anaesth Publication Date: 2004 Apr |
Date Detail:
|
Created Date: 2004-04-13 Completed Date: 2004-07-22 Revised Date: 2005-11-16 |
Medline Journal Info:
|
Nlm Unique ID: 9206575 Medline TA: Paediatr Anaesth Country: France |
Other Details:
|
Languages: eng Pagination: 293-8 Citation Subset: IM |
Affiliation:
|
Clinical Nurse Specialist in Pain, Royal Liverpool Children's Hospital - Alder Hey, Eaton Road, Liverpool, UK. mary@cunliffe7714.freeserve.co.uk |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics
/
adverse effects,
therapeutic use Child Chloral Hydrate / administration & dosage, adverse effects Clinical Protocols Follow-Up Studies Hospital Units* Humans Hypnotics and Sedatives / administration & dosage*, adverse effects Infant Intensive Care* Length of Stay* Male Midazolam / administration & dosage, adverse effects Pain Clinics Patient Care Planning Patient Transfer* Substance Withdrawal Syndrome / prevention & control* Time Factors Writing |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics; 0/Hypnotics and Sedatives; 302-17-0/Chloral Hydrate; 59467-70-8/Midazolam |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Trauma-induced cutaneous pigmentation from tetracycline: a case report.
Next Document: Providing parents with information before anaesthesia: what do they really want to know?